The selective use of antibiotic treatment for clinical mastitis: Benefits and Practical Application

Our first TotalDairy Learning Live session with Sofie Piepers, Sponosred by Boehringer Ingleheim, on 21st May will explore the latest advancements in selective treatment of non-severe clinical mastitis, equipping you with the knowledge and practical tools to implement this approach effectively on your farm.

Join us to discover how selective treatment can enhance herd health, improve efficiency, and align with evolving industry and consumer expectations.

Sofie Piepers will be covering:

• The concept of selective treatment of non-severe clinical mastitis.
• Benefits of selective treatment: from reduced antibiotic use over minimizing milk discard periods to better meeting modern societal expectations.
• Practical implementation of selective treatment on the farm: from science into practice including some practical examples.

Sofie Piepers Biography
In 2005, Sofie Piepers graduated as a veterinarian at the Faculty of Veterinary Medicine of Ghent University, Belgium and since that time she has been a member of M-teamUGent (www.m-team.UGent.be). She is passionate about mastitis and milk quality.

As a veterinarian and researcher, she loves networking, collecting new information at scientific conferences, and later turning that knowledge into practice. Sofie is since 2015 managing director of MEX™, a spin-off company of Ghent University. Driven by passion, inspired by science and strengthened by more than 20 years of experience, the team at MEX™ works to create holistic, integrated solutions for easy mastitis management through evidence-based consultancy, collaboration with more than 25 industry experts, first class training, coaching and mentoring, and mastitis data management. As visiting professor at the Faculty of Veterinary Medicine of Ghent University, she is still involved in the research projects within the Mastitis and Milk Quality Research Unit.

Sponsors
Boehringer Ingelheim
Boehringer Ingelheim Animal Health is working on first-in-class innovation for the prediction, prevention, and treatment of diseases in animals.

For veterinarians, pet owners, farmers, and governments in more than 150 countries, we offer a large and innovative portfolio of products and services to improve the health and well-being of companion animals and livestock.

As a global leader in the animal health industry and as part of family-owned Boehringer Ingelheim, we take a long-term perspective. The lives of animals and humans are interconnected in deep and complex ways. We know that when animals are healthy, humans are healthier too. By using the synergies between our Animal Health and Human Pharma businesses and by delivering value through innovation, we enhance the health and well-being of both.